These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 38257151)

  • 1. Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions.
    Bell V; Varzakas T; Psaltopoulou T; Fernandes T
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional perspectives on sickle cell disease in Africa: a systematic review.
    Nartey EB; Spector J; Adu-Afarwuah S; Jones CL; Jackson A; Ohemeng A; Shah R; Koryo-Dabrah A; Kuma AB; Hyacinth HI; Steiner-Asiedu M
    BMC Nutr; 2021 Mar; 7(1):9. PubMed ID: 33731225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa.
    Bello-Manga H; DeBaun MR; Kassim AA
    Expert Rev Hematol; 2016 Nov; 9(11):1031-1042. PubMed ID: 27677923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation science research for the scale-up of evidence-based interventions for sickle cell disease in africa: a commentary.
    Gyamfi J; Ojo T; Iwelunmor J; Ogedegbe G; Ryan N; Diawara A; Nnodu O; Wonkam A; Royal C; Peprah E
    Global Health; 2021 Feb; 17(1):20. PubMed ID: 33596947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between nutrition, gut dysbiosis, and pediatric sickle cell pain outcomes: A pilot study.
    Dike CR; Hanson C; Davies HD; Obaro S; Yu F; Harper J; Grace H; Lebensburger J; Raulji C; Ma J; Mannon P
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30397. PubMed ID: 37101362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Sickle cell disease: Causes, symptoms, and treatment options.
    Elendu C; Amaechi DC; Alakwe-Ojimba CE; Elendu TC; Elendu RC; Ayabazu CP; Aina TO; Aborisade O; Adenikinju JS
    Medicine (Baltimore); 2023 Sep; 102(38):e35237. PubMed ID: 37746969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Intestinal Microbiota in Children With Sickle Cell Disease.
    Karahan F; Yilmaz SS; Bayrakdar F; Tezol Ö; Kuyucu N; Kiliç S; Türkegün M; Ünal S
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e904-e909. PubMed ID: 37526399
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.